chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a female medical assistant of unknown age with sulfa allergy and no pertinent medical history. The medical assistant was administering a dose of lot # (1418AA; exp date 25-MAY-2013) PNEUMOVAX23 (dose not reported) to a patient on 11-SEP-2012 and some vaccine splashed in the right eye and face. No other co-suspects were reported. There were no concomitant medications. On 11-SEP-2012 the medical assistant's face was burning but the right eye had no symptoms. The nurse stated that the needle was not put on correctly. The right eye was flushed out for 5 minutes and was going to be flushed out for an additional 10 minutes and wash the face area that was burning. No lab diagnostic tests were performed. The patient sought unspecified medical attention. On 11-SEP-2012 the patient recovered from the reported events. Additional information has been requested.
While the intern was giving the vaccine, the medication leaked/squirted out from the top of the syringe.  She immediately informed the pharmacist on duty; in which we contacted our clinical team to get direction on giving a new full dose of vaccine or not.  They informed us to give the shot in the other arm & the full dose.
8OCT devel fever inc 104 even w/APAP; slight rash, irritable; ER-t103 pt irritable?, pale, sensitivity to light, throat reddened, asthma;
Headache, dizziness, throwing up, tired most of the time. High blood pressure and heartbeat about 140-150 beats per minute. Fever 103. No appetite and dehydration.
Note: I was unable to list information for both doses but I don?t think it was just the second one that affected me. I think they both did me in.  Symptoms: -Severe, debilitating brain fog and derealization that worsen with physical exertion -Fatigue to the point of being bedbound at times, with cyclical ?crashes? -General flu-like malaise, soreness, weakness -Occasional back and joint pain -Headaches (almost never got these before) -Insomnia, frequent waking in night -Heart often feels like it?s racing/pounding -Blood rushes to head and vision blurs/goes black upon standing -Ringing in ears -Swollen hard lymph nodes in neck -Sore throat that comes and goes -Worsened GI distress -New intolerance to substances (e.g. caffeine, alcohol) and medications, strange new side effects
The day after getting the shot I had soreness in left arm, severe body aches and pain, no fever, chills. Felt  really cold to the bones and my teeth would chatter.
Started last night-Injection site became itchy, very red and has welts. Also warm to touch. Is getting more sore and red as day goes.
Missed the 3rd dose and took it late; A spontaneous report was received from a caregiver on 31OCT2022. It described a male patient of unknown age who "missed the 3rd dose and took it late" (PT: Inappropriate schedule of product administration). The patient took the Vivotif (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunization. It was reported that the patient missed his third dose of Vivotif which was to be administered on Friday (as per the reporting) and took it on 31OCT2022 (today- as per reporting). The outcome of the reported event was not applicable.  Action taken with Vivotif with respect to the reported event was not applicable.  No additional information was reported.  Company comment: It was reported that a patient missed the 3rd dose and took it late (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event. The case is considered non-serious as per medical assessment.; Sender's Comments: It was reported that a patient missed the 3rd dose and took it late (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event. The case is considered non-serious as per medical assessment.
Feel a little under the weather; Sick to stomach; Queezy; Feels like has a cold; This case was reported by a consumer via call center representative and described the occurrence of feeling abnormal in a 68-year-old patient who received Herpes zoster (Shingrix) (batch number EG55L, expiry date unknown) for prophylaxis.   Previously administered products included Zostavax (received Zostavax 6 to 7 years ago from the time of reporting).   On 25th October 2019, the patient received the 1st dose of Shingrix (intramuscular). In October 2019, less than a week after receiving Shingrix, the patient experienced feeling abnormal, stomach discomfort, queasy and cold. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the feeling abnormal, stomach discomfort, queasy and cold were not recovered/not resolved.   It was unknown if the reporter considered the feeling abnormal, stomach discomfort, queasy and cold to be related to Shingrix.  Additional details were provided as follows: The patient experienced sick to stomach, queezy, felt like had cold and felt like under the weather. The patient asked whether it is common to feel a little under the weather after vaccination. The patient gave permission to contact healthcare provider.
Vaccine was given unknowingly to a patient under the age of 18. She was not accompanied by a parent/guardian. She was "eligible" to receive the vaccine due to being a grocery store employee, but was not indicated to receive the Moderna vaccine at her age. There has been no adverse event reported as a result of her receiving vaccine.
Patient received Moderna 2nd dose too early.  1st dose administered 5/27/21 2nd dose administered 6/18/21
headache for 3 days,  tired and fatigued for 3 days, injection site  pain 2 days
pt recv vax 4PM & started itching 425PM;denies c/o SOB;02 sat w/room air 99-100%;50mg of DPH given IM;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Patient's medical history was not reported. On 23-MAY-2014 the patient was inadvertently vaccinated with a less than complete dose of ZOSTAVAX (subcutaneous, lot#, expiration date, anatomical location not reported) due to leakage from the needle. Concomitant medications were not reported. No adverse effects reported. Additional information has been requested.
Pt noted nausea, "queasy", feeling after H1N1 vaccine. Was starting to eat lunch at the time. Alleged to be confused-tachypneic on arrival at ER. Vs all stable, pulse ox 100%, observed for several hrs.
Within 72 hours of my 2nd dose, I experience extreme vertigo with dizziness, nausea, and ringing in my left ear (tinnitus). The vertigo symptoms subsided after 2-3 days and treatment in the emergency room however the tinnitus has become permanent in my left ear for over 3 weeks now. It is loud enough to disrupt my sleeping and my ability to hear from my left ear. I still have slight dizziness spells intermittently. Additionally, I have begun to experience extreme arthritis and muscular pain throughout my body, which begun 2 weeks after the 2nd dose. I have begun to lose function intermittently of my feet, fingers, and arms at different times throughout the day.
Information has been received from a health professional concerning a 5 year old white male with asthma, seasonal allergies, an amoxicillin allergy, hyperglycemia and a history of chicken pox exposure who on 8/12/98, at 6:00 PM, was vaccinated SC in the lateral thigh with a first dose of varicella virus vaccine live (lot # 624724/01327E). On 12/31/02, at 9:00 PM, the child broke out with a chicken pox rash. The rash began on the torso area and spread over the entire body including the face, genitalia and scalp. He was afebrile. The rash dried and cleared up by 1/6/03. It was noted that his chicken pox exposure was 7-10 days prior to breaking out. Medical attention was not sought. Additional information is not expected.
This case was reported by a other health professional via call center representative and described the occurrence of fever in a 5-month-old female patient who received DTPA vaccine. On 31st October 2003, the patient received the 2nd dose of DTPa vaccine. On an unknown date, an unknown time after receiving DTPa vaccine, the patient experienced fever and crying. On an unknown date, the outcome of the fever and crying were recovered/resolved. It was unknown if the reporter considered the fever and crying to be related to DTPa vaccine. Additional details provided were as follows: The patient received an unspecified brand of DTPa vaccine. The patient experienced high fever and cried for days. No further information regarding the reported events was available.
Client was inadvertently vaccinated 3 times. When submitted info into the system it was discovered that she had already had two doses given.  Client did not complain of any side effects or adverse reactions.
fever up to 104x24hrs then 102x48hrs. Vomited x 12hrs. Lethargic x 3days.
Subsequent to receiving varicella virus vaccine live on 06/10/99, the pt presented to her physicians office in 08/99 with a "diffuse case of chickenpox." It was reported that the child had "many lesions and a low grade fever." Additional information has been requested.
Information has been received from a Doctor in osteopathy concerning an unknown number of patients of unknown age and sex. On unspecified dates, the patients were vaccinated with "the second or third" dose of GARDASIL (dose and route were not reported) (lot # and expiration date were not reported). The physician reported that on unknown dates the patient experienced "more adverse events after receiving second or third dose of GARDASIL". It was unknown if the patients sought medical attention. At the time of the report, the patient's outcomes were unknown. The relatedness of GARDASIL and the event was not reported. Additional information has been requested.
This spontaneous report as received from a nurse via Pfizer sales representative refers to a female patient of unknown age. No concurrent conditions, medical history and concomitant medications were reported On an unknown date, the patient was vaccinated PREVNAR 13 (dosing details, lot# and expiry date were not reported) and then 8 weeks later the patient was vaccinated with PNEUMOVAX 23 (dosing details, lot# and expiry date were not reported). Post vaccination with PNEUMOVAX 23, the patient experienced rash and swelling of the arm. The outcome of rash and swelling of the arm was unknown. The reporter did not provide the causality between rash and swelling of the arm and the suspect therapies. Additional information has been requested.
Vaccine given on 04/08/2002 in left deltoid. Pt phoned on 04/09/2002 to report upper arm to be swollen and hot to touch. Pt instructed to use Ibuprofen and hot packs to area. Pt seen on 04/10/2002 with worsening swelling noted diffuse swelling, high temp, erythema of entire left upper arm. Pt given Prrednisone for five days. Pt returned on 04/11/2002 with continuation of same symptoms. No further treatment needed.
wheezy; diarrhea; arm hurt a little bit; Throwing up; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (wheezy), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (arm hurt a little bit) and VOMITING (Throwing up) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced WHEEZING (wheezy), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (arm hurt a little bit) and VOMITING (Throwing up). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, WHEEZING (wheezy), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (arm hurt a little bit) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines were not provided  Treatment drug include Tylenol  Action taken with mRNA-1273 in response to the event was unknown
RAPID HEARTBEAT, EXCESSIVE PHLEGM, TROUBLE BREATHING AFTER BRIEF WALKS AND RUNS, HIGH HEARTBEAT TO WHERE CHEST HEARTS.
Left hard pain in shoulder and scapula, enlarged lymp noded under left arm, 3 growths in breast that were removed and benign and I was clear in October by an MRI prior. Had to have a surgical biopsy as I had a bilateral mastectomy in 2017 and reconscrution and was clear for 4 years. Lost a patch of hair after vaccine on left side of head.
I gave HPV first in LA and patient was standing and appeared fine. I then gave the Menactra vaccine in the RA and patient immediately fainted and body stiffened for less than one minute. She then quickly reoriented and stood up and she was fine. Had two dizzy spells while sitting down, but they resolved w/ her head b/w legs. Monitored pt x2: 1st laying then sitting, then standing.
Janssen Covid-19 Vaccine EUA  Slight headache  Itching at injection site muscle aches nausea fever  wheezing
Clinician who administered the vaccine (RN) felt that the patient received less then half the dose administer as the rest of the serum leaked from the syringe. Talked to the patient and decided that the best course of action was to revaccinate / administer another dose.
Reported Symptoms: 10003239: ARTHRALGIA; 10016256:FATIGUE; 10022086:INJECTION SITE PAIN; 10047862:WEAKNESS;  Narrative: Other Relevant RX:  INTERVENTIONS REQUIRED FOR ADE:  Use of Antypyretic (Specify):APAP 650mg po q6h prn (has not taken any medication - recommended APAP)  IMPACT ON FUNCTION: reports that he received covid vaccine 2 days ago and developed joint pain, weakness, fatigue. "took my 3x longer to make my breakfast this morning and i couldnt participate fully in PT".  reports difficulty raising arm that was vaccinated.    reports that he is still able to eat/drink fluids normally - encouraged increase hydration  recommended to follow up w/PCP if symptoms get worse or do not improve patient reported that he had never had a reaction to the covid vaccine prior  Other: WEAKENSS; FATIGUE;  INJECTION SITE PAIN
Myalgia, Arthralgia, Fever & NauseaVomiting Narrative:  Pt reports that several hours after receiving second dose she began having fever/chill, body aches and nausea. Temp 100.9 F. She self-treated with OTC Tylenol. Symptoms lasted approximately 12 hours and resolved spontaneously.  Other Relevant History:
PATIENT RECEIVED VACCINE THEN BECAME DIZZY WHEN ENTERING THE OBSERVATION AREA.  WAS LOWERED TO THE FLOOR WITH ASSISTANCE FROM ANOTHER PATIENT.  FAINTED BUT RECOVERED WITHIN 10 SECONDS.  NURSES MONITORED FOR EXTENDED PERIOD OF TIME.
Information has been received from a 70 year old male with Parkinson's disease and no allergies who on 01-APR-2007 was vaccinated with a dose of Zostavax (Oka/Merck). Concomitant therapy included LORTAB, amitriptyline hydrochloride (MSD) and "LIQUIP.". On 15-JUN-2007, the patient developed breakthrough shingles. The shingles were on the left side of his head and neck. The scabs went away but the pain was still present. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been received from a nurse who reported that the patient recovered on an unspecified date. No further information is expected.
received expired dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired dose). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (received expired dose) had resolved.            Concomitant medication information was not provided by the reporter.                             Treatment information was not provided by the reporter.
This spontaneous report as received from a registered nurse refers to a 19 year old patient (gender not specified). On 14-MAR-2013 the adult patient was vaccinated with a pediatric booster dose of VAQTA dose 1, (0.5 ml, intramuscular). On 16-MAR-2013 the patient received a second dose of pediatric VAQTA. Lot no. information was not provided. No adverse effect reported. Additional information has been requested.
Information has been received from a physician concerning a patient who "4-5 years ago", in approximately 2005 was vaccinated with the last dose of GARDASIL. The physician stated that the patient was given 3 doses of GARDASIL and then developed multiple sclerosis. The outcome of the patient was not reported. It was unknown if the patient sought medical attention. It was reported that there were a lot of "ambiguity" surrounding this patient. Multiple sclerosis was considered to be an other important medical event. Additional information has been requested.
10/19 begin to feel bad, 10/21 high fever will not come down even with Tylenol or Advil,  10/24 ER chest X ray diagnosed with pneumonia, 10/25 Dr appt to check medication, 10/29 noticed weakness in legs beginning in morning balance problems and weakness worsen, 10/30, ambulance to ER, 11/02 spinal tap clear symptoms paralysis, foot drop, muscle spasms, inflamed nerve endings in legs and feet, 11/04 transferred to another hospital, 11/04 extremely high protein level in blood due to deterioration of muscles. Start on baclofen to stop spasms, 11/09 protein level back to normal, 11/11 transferred to rehab Unit cannot walk at all, 11/14-22 physical therapy 4 times a day for 45 minutes. Learn to walk again, balance problems, diagnosed with Post infectious myositis, released 11/22 on going therapy to improve function. 11/25 begin outpatient therapy 3 times a week on going due to peroneal nerve damage in feet. I have peroneal neuropathy- foot drop due to flu vacine. Swelling of feet and ankles, pain in feet, decreased movement, no feeling in toes ore feet. Still go to physicial therapy to regain strength and flexability. Constatn muscle spasms in feet. Nerve damage from ankles down. 3/31/2010 Follow up: No feeling in feet and legs due to damage to peroneal nerve. Loss of movement in ankles/swelling in feet neurological problems-short term memory loss, difficulty in concentration and difficulty finding words and thoughts.
Within 10 minutes patient with complaints of shortness of breath, tongue discomfort and roof of mouth discomfort. Patient states that he also had a weird taste in his mouth. NP and paramedics at patient side. Patient appeared anxious. Lungs clear, posterior pharynx normal, uvula with no inflammation noted. Legs elevated. Patient placed on O2 and initial vitals normal. Patient then became hypertensive with SOB. Patient states that he can not take Benadryl because his doctor advised him not to ever take it. Patient is unsure if allergy. Initial EKG patient with inverted Twaves on 4 lead, then patient with normal EKG with 12 lead. Patient given 0.3mg of Epi and fire rescue notified. Fire Rescue arrived at 1256 and patient transported to  ER at 1pm. Patient remained with weird feeling to tongue and roof of mouth on transport, shortness of breath was improving.
Pt recvd Hep B vax 3yrs ago & did not seroconvert; On 9APR92 pt had a cold recvd a dose of Hep B vax & on 10APR92 pt exp nausea, vomiting & diarrhea;
Site: Pain at Injection Site-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium, Systemic: Hypotension-Medium, Systemic: Shakiness-Medium
Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  Additional Information: Patient and his wife both received first CoVax 02Mar2021, asked if could take Ibuprofen after receiving CoVax. Reported experiencing "Sore arm" after CoVax, and mentioned wife wants to take Ibuprofen because she has a ''sore back''.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
COUGH; WHEEZING; FATIGUE/ FEELING RUN DOWN; This spontaneous report received from a patient concerned a 57 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-MAR-2021, the subject experienced fatigue/ feeling run down. On an unspecified date, the subject experienced cough, and wheezing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fatigue/ feeling run down, and had not recovered from cough, and wheezing. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
This spontaneous report as received from a pharmacist refers to a currently 72 year old female patient with no drug reactions/allergies. The pharmacist reported that on 21-FEB-2015 the patient received ZOSTAVAX (lot # K016325, expiration date 24-DEC-2015, 0.65 ml, subcutaneously). On an unknown date the patient experienced hemorrhoids. On 25-FEB-2015 (also reported as today) the patient came to the pharmacy to have a prescription for hydrocortisone rectal suppositories filled, that were prescribed for hemorrhoids. The patient's outcome was reported as not recovered. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
Had my first vaccine over 6 weeks ago; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Had my first vaccine over 6 weeks ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Had my first vaccine over 6 weeks ago). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Had my first vaccine over 6 weeks ago) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       THERE ARE NO CONCOMITENT MEDICATIONS IN THE TREATEMENT
Was diagnosed influenza A, influenza B, and pneumonia. After having a good prognosis she died. She has both influenza and pneumonia vaccines in the fall.
Swollen hand, heavy breathing, sweaty (also thought he might be having a panic attack)
4 Hours after shot, with fevers, sweating, nausea with no vomiting.  Pain from shoulder to elbow.  Lasted 4 hours. Not pregnant.